Finance

Beta
Lists
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$2.05
+4.59%
(+0.090) 1D
$2.06
+0.35% (+0.0072)
After hours
Closed: Jun 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$1.95
High
$2.15
Low
$1.95
Mkt. cap
123.66M
Avg. vol.
1.04M
Volume
1.69M
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
Open
$1.95
High
$2.15
Low
$1.95
Mkt. cap
123.66M
Avg. vol.
1.04M
Volume
1.69M
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
News stories
From sources across the web
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees7
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com
Analyst Ratings
Based on 1 analyst giving stock ratings to ALDX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for ALDX in the last 3 months.
Highest
Current $2.05
$2.00 (-2.44%)
Average
$2.00 (-2.44%)
Lowest
$2.00 (-2.44%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Matthew Caufield
H.C. Wainwright
Hold
Reiterated
$2.00
-2.4%
05/11/2026
Thomas Shrader
BTIG
Buy
Maintained
$9.00
+339%
03/17/2026
Clara Dong
Jefferies
Buy
Maintained
$7.00
+241.5%
10/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.51M
5.43M
4.30M
2.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
2.57M
2.36M
1.14M
Operating expense
10.17M
8.00M
6.67M
3.55M
Total operating expenses
10.17M
8.00M
6.67M
3.55M
Operating income
-10.17M
-8.00M
-6.67M
-3.55M
Other non operating income
-
-
-
-
EBT including unusual items
-9.77M
-7.69M
-6.46M
-3.45M
EBT excluding unusual items
-9.77M
-7.69M
-6.46M
-3.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.77M
-7.69M
-6.46M
-3.45M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.13
-0.10
-0.06
Interest and investment income
872.04K
788.69K
681.64K
562.98K
Interest expense
-470.62K
-475.90K
-475.26K
-468.68K
Net interest expenses
401.42K
312.79K
206.38K
94.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.11M
-7.94M
-6.60M
-3.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer